ANXA1 and nasopharyngeal carcinoma: A study showed that the inhibition of ANXA1 in nasopharyngeal carcinoma increased the trauma-healing ability of the cells, and the activation of the ANXA1 gene decreased the trauma-healing rate by 70%.